Table 2.
Patient | Age | Histologic Type | Clinical Stage | Tumor Size | Laterality | Body Mass Index | Hormonal Receptors | Molecular Classification | ||
---|---|---|---|---|---|---|---|---|---|---|
PR | ER | HER Status | ||||||||
4E | 81 | Lobulillar infiltrating | T3N4M0 | 5 × 7 cm | Left | 37.4 | + | + | − | Luminal A |
6F | 60 | Canalicular infiltrating | T4bN2M0 | 5 × 6 cm | Left | 30.1 | − | − | − | Basal-like |
23G | 45 | Canalicular infiltrating | T4N0M0 | 6 × 4 cm | Right | 32.1 | + | + | − | Luminal A |
30H | 56 | Ductal infiltrating | T4N0M0 | 5 × 5 cm | Right | 29.6 | + | + | − | Luminal A |
9A | 46 | Ductal infiltrating | T3N1M0 | 6 × 6 cm | Left | 27.2 | + | − | + | Luminal B |
11B | 63 | Ductal infiltrating | T2N1M0 | 3 × 2 cm | Left | 25.6 | − | − | + | Her2+ |
14C | 46 | Canalicular infiltrating | T3N1M0 | 5 × 3 cm | Left | 31.2 | − | − | − | Basal-like |
19D | 72 | Lobulillar infiltrating | T4BN0M0 | 3 × 2 cm | Left | 22.8 | + | + | − | Luminal A |
Abbreviations: ER, estrogen receptor; HER, human epidermal growth factor receptor; M, metastasis; N, node; PR, progesterone receptor; T, tumor.